# US 5,710,294 A · 19-nor vitamin D compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 5,710,294 A
- Document ID: US5710294A
- Status: Granted
- Kind: A
- Application number: 08/558,221
- Filed: 1995-11-17
- Granted: 1998-01-20
- Earliest claimed: 1989-03-09
- Assignees: Wisconsin Alumni Research Foundation
- Inventors: Hector F. DeLuca; Heinrich K. Schnoes; Kato L. Perlman; Rafal R. Sicinski; Jean Martin Prahl
- Web page: https://patentgrep.com/patent/US5710294A

## CPC

- C07C 401/00: Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
- A61P 5/12: for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A61P 17/00: Drugs for dermatological disorders
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

This invention provides a novel class of vitamin D-related compounds, namely the 1.alpha.-hydroxy-19-nor-vitamin D analogs, as well as a general method for their chemical synthesis. The compounds exhibit pronounced activity in arresting the proliferation of undifferentiated cells, including malignant cells, and in inducing their differentiation, and thus represent novel therapeutic agents for the treatment of malignant and other diseases characterized by the proliferative growth of undifferentiated cells. Formulations for therapeutic use and treatment methods are also provided.

## Claims

### Claim 1

A compound having the formula ##STR9## where R is a side chain selected from the group consisting of alkyl, hydrogen, hydroxyalkyl, fluoroalkyl and a side chain of the formula ##STR10## wherein R.sup.1 represents hydrogen, hydroxy or O-acyl, R.sup.2 and R.sup.3 are each selected from the group consisting of alkyl, hydroxyalkyl and fluoroalkyl, or, when taken together represent the group--(CH.sub.2).sub.m --where m is an integer having a value of from 2 to 5, R.sup.4 is selected from the group consisting of hydrogen, hydroxy, fluorine, O-acyl, alkyl, hydroxyalkyl and fluoroalkyl, R.sup.5 is selected from the group consisting of hydrogen, fluorine, alkyl, hydroxyalkyl and fluoroalkyl, or, R.sup.4 and R.sup.5 taken together represent double-bonded oxygen, R.sup.6 and R.sup.7 are each selected from the group consisting of hydrogen, hydroxy, O-acyl, fluorine and alkyl, or, R.sup.6 and R.sup.7 taken together form a carbon-carbon double bond, and wherein n is an integer having a value of from 1 to 5 and wherein any of the groups --CH(CH.sub.3)--, --CH(R.sup.7)--, or --CH(R.sup.6)-- at positions 20, 22 and 23, respectively, may be replaced by an oxygen atom, Q represents an alkyl, X is selected from the group consisting of hydrogen, acyl, alkylsilyl and alkoxyalkyl and Y is selected from the group consisting of hydroxy, hydrogen and protected hydroxy where the protecting group is acyl, alkylsilyl or alkoxyalkyl.

### Claim 2 (depends on 1)

The compounds of claim 1 where R is a side chain of the formula ##STR11## Q is methyl and X is acyl.

### Claim 3 (depends on 1)

The compounds of claim 1 where R is a side chain of the formula ##STR12## Q is methyl and X is acyl.

### Claim 4 (depends on 1)

The compounds of claim 1 where R is a side chain of the formula ##STR13## Q is methyl and X is acyl.

### Claim 5 (depends on 1)

The compounds of claim 1 where R is a side chain of the formula ##STR14## Q is methyl and X is acyl.